Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2007-05-22 |
| Study Made Public: | 2011-06-21 |
Title
Comparative analysis of CN54 gp140 immunogenicity in 3 different adjuvants
Description
CAVD 285 is a continuation of CAVD 284, assessing the neutralization activity induced by the clade C trimeric gp140 antigen derived from clade C HIV-1 CN54, combined with different adjuvants.
Sign in to see full information about this study and to download study data.